Market Signal Briefing

NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of ordinary shares, including those that sold into the Merger of Sina Corporation (NASDAQ: SINA) between October 13, 2020 and March 22, 2021, both dates inclusive (the “Class Period”), of the important November 18, 2025 lead plaintiff deadline.

SO WHAT: If you sold Sina ordinary shares, including those that sold into the Merger, during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Sina class action, go to https://rosenlegal.com/submit-form/?case_id=45219 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 18, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants created a fraudulent scheme to depress the value of Sina ordinary shares to avoid paying a fair price to Sina’s shareholders in connection with the Merger. Defendants executed this scheme by misrepresenting and/or omitting material information within and from Sina’s proxy materials in connection with the Merger that were necessary for shareholders to make an informed decision concerning whether to vote in favor of the Merger. Specifically, defendants failed to disclose that: (1) defendants concealed the true value of Sina’s investment in TuSimple at the time of the Merger; (2) in turn, the offer of $43.30 per ordinary share as consideration for the Merger substantially shortchanged the true value of Sina ordinary shares; and (3) as a result, defendants’ statements about Sina’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

To join the Sina class action, go to https://rosenlegal.com/submit-form/?case_id=45219 call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

The Exxon Mobil Corp building is pictured in Georgetown, Guyana February 18, 2022. REUTERS/Sabrina Valle Purchase Licensing Rights, opens new tab

CompaniesNEW DELHI/SINGAPORE, Oct 17 (Reuters) - Two Indian refiners have bought 4 million barrels of Guyanese crude oil from U.S. major Exxon Mobil

(XOM.N), opens new tab to be delivered at end-2025 or in early 2026, in their first imports from the South American producer, trade sources said on Friday.

Indian Oil Corp

(IOC.NS), opens new tab, the country's largest refiner by capacity, has bought 2 million barrels of Golden Arrowhead crude which will arrive in late December or in early January, they said, speaking on condition of anonymity.

Sign up here.

Another refiner, Hindustan Petroleum Corp

(HPCL.NS), opens new tab, has bought 2 million barrels of Liza and Unity Gold crude also for delivery during the same period, the sources said.

Reporting by Nidhi Verma in New Delhi and Florence Tan in Singapore; Editing by Clarence Fernandez

Our Standards: The Thomson Reuters Trust Principles., opens new tab

NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) resulting from allegations that Telix may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased Telix securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=43778 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

WHAT IS THIS ABOUT: On July 22, 2025, Telix disclosed receipt of a subpoena from the U.S. Securities and Exchange Commission, which was “seeking various documents and information primarily relating to the Company’s disclosures regarding the development of the Company's prostate cancer therapeutic candidates.”

On this news, Telix’s American Depositary Receipt (“ADR”) price fell $1.70 per ADR, or 10.44%, to close at $14.58 per ADR on July 23, 2025.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

Starbucks is assessing bids from five parties for its China business as it seeks a partner to navigate the country's competitive coffee landscape.

October 16, 2025 22:30 ET

 | Source:

Westhaven Gold Corp.

VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Westhaven Gold Corp. (TSX-V:WHN) announces that it has been made aware that the proceeding against its former Chief Financial Officer, Shaun Pollard, in which it was alleged that Mr. Pollard contravened certain provisions of the Securities Act (British Columbia) stemming from conduct which took place in September 2018, was stayed on October 9, 2025. The Company understands that the stay of the proceeding has effectively resulted in the termination of the prosecution against Mr. Pollard.

No similar allegations were ever made against the Company or any of its directors or other officers.

“We are relieved that the protracted legal process concerning our former CFO, Shaun Pollard has now been resolved with an outcome that reflects his steadfast position throughout," said Eira Thomas, Westhaven Gold Chairperson. "We extend our best wishes to Mr. Pollard and his family as they are now able to move forward with future, productive endeavours. Westhaven remains focused on advancing our exploration programs and creating value for our shareholders, while continuing to maintain high standards of corporate governance and regulatory compliance.”

On behalf of the Board of Directors

WESTHAVEN GOLD CORP.

“Ken Armstrong”

Ken Armstrong, President and CEO, is responsible for this news release and can be reached at 604-681-5558.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

These companies pay high-yielding and steadily rising dividends backed by strong financial profiles.

I love to collect dividend income. It provides me with more cash to invest each month and a growing level of financial freedom. My goal is to eventually generate enough passive income from dividends and other sources to cover my basic living expenses.

To support my income strategy, I focus on buying high-yielding dividend stocks. Two companies in particular, Brookfield Infrastructure (BIPC -2.38%) (BIP -1.62%) and W.P. Carey (WPC -0.04%), have consistently stood out. Here's why I can't stop buying these income stocks.

Image source: Getty Images.

A high-octane dividend growth stock
Brookfield Infrastructure currently yields nearly 4%, more than triple the S&P 500's dividend yield (1.2%). The global infrastructure operator supports its high-yielding payout with very stable cash flows. Long-term contracts and government-regulated rate structures account for around 85% of its annual funds from operations (FFO). Most of those frameworks have no volume or price exposure (75%), while another large portion of its cash flow (20%) comes from rate-regulated structures that only have volume exposure tied to changes in the global economy. The bulk of these arrangements also either index its FFO to inflation (70%) or protect it from the impact of inflation (15%).

The company pays out 60% to 70% of its very resilient cash flow in dividends. That gives it a comfortable cushion while allowing it to retain a meaningful amount of cash to invest in expansion projects. Brookfield also has a strong investment-grade balance sheet. Additionally, the company routinely recycles capital by selling mature assets to invest in higher-returning opportunities.

Brookfield has grown its FFO per share at a 14% annual rate since its inception in 2008, supporting a 9% compound annual dividend growth rate. While its growth has slowed in recent years due to headwinds from interest rates and foreign exchange fluctuations, a reacceleration appears to be ahead. The company believes that a combination of organic growth driven by inflationary rate increases, volume growth as the economy expands, and expansion projects will drive robust FFO per share growth in the coming years. Additionally, it expects to get a boost from its value-enhancing capital recycling strategy. These catalysts should combine to drive more than 10% annual FFO per share growth.

The company's strong financial profile and robust growth prospects easily support its plan to increase its high-yielding payout at a 5% to 9% annual rate. Brookfield has increased its payout in all 16 years since it went public.

Rebuilt on an even stronger foundation
W.P. Carey has a 5.4% dividend yield. The real estate investment trust (REIT) owns a well-diversified portfolio of operationally critical real estate across North America and Europe. It focuses on investing in single-tenant industrial, warehouse, retail, and other properties secured by long-term net leases featuring built-in rental escalation clauses. Those leases provide it with very stable and steadily rising rental income.

The REIT has spent the past few years reshaping its portfolio. It accelerated its exit from the office sector in late 2023 by spinning off and selling its remaining properties. W.P. Carey has also been selling off some of its self-storage properties, particularly those not secured by net leases. It has been recycling that capital into properties with better long-term demand drivers, such as industrial real estate.

W.P. Carey's strategy should enable it to grow its adjusted FFO at a higher rate in the future. Its portfolio is delivering healthy same-store rent growth (2.3% year-over-year in the second quarter). Meanwhile, its investments to expand its portfolio are driving incremental FFO per share growth. W.P. Carey is on track to grow its adjusted FFO per share by 4.5% at the mid-point of its guidance range this year.

That growing income is allowing the REIT to increase its dividend. It has raised its payment every quarter since resetting the payout level in late 2023 when it exited the office sector, including a 4% increase over the past 12 months. With a strong portfolio and balance sheet, W.P. Carey has the financial flexibility to continue growing its portfolio, FFO, and dividend in the coming years.

High-quality, high-yielding dividend stocks
Brookfield Infrastructure and W.P. Carey stand out for their stable and growing cash flows, as well as high-yield dividends. Brookfield offers inflation-protected cash flows that minimize risk, while W.P. Carey generates reliable rental income from long-term leases. With lots of income and growth ahead, I just can't stop buying these high-quality, high-yielding dividend stocks.

Matt DiLallo has positions in Brookfield Infrastructure, Brookfield Infrastructure Partners, and W.P. Carey. The Motley Fool recommends Brookfield Infrastructure Partners. The Motley Fool has a disclosure policy.

SummaryBetterware is rated a 'Buy' with a price target of ~$17.75, offering ~40% upside plus a high dividend yield.BWMX benefits from real wage gains in Mexico's lower/middle class, an asset-light model, and strong cash flow, but faces cyclical and competitive risks.Jafra's integration boosts cross-selling and margins, yet faces intensifying competition from Natura/Avon, especially in Mexico's DTC cosmetics market.The current 9% dividend yield appears sustainable given robust FCF, though payouts have been irregular and future margin pressure is expected. Getty Images

Investment Thesis Betterware (NYSE:BWMX) is an overlooked high-yield stock that's a perfect fit if you want to expose your portfolio to Mexico's discretionary consumer environment. Real wage gains, healthy employment levels, and monetary easing should continue to drive lower-middle-class

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

October 16, 2025 8:51 PM EDT | Source: Wilton Resources Inc.
Calgary, Alberta--(Newsfile Corp. - October 16, 2025) - Wilton Resources Inc. (TSXV: WIL) (the "Corporation") is pleased to announce that it closed its non-brokered private placement of units of the Corporation ("Units") at a purchase price of $0.35 per Unit for total aggregate gross proceeds of $782,669.90 (the "Offering"). The principal use of the proceeds of the Offering will be for general corporate purposes and as a reserve to pursue the acquisition of an international oil and gas property.

Each Unit is comprised of one common share in the capital of the Corporation ("Common Share") and one Common Share purchase warrant ("Warrant"). Each Warrant entitles the holder to purchase one Common Share for a period of 12 months from the date of issuance at an exercise price of $0.45.

The Corporation paid a finder's fee to Haywood Securities Inc. ("Haywood") consisting of a cash payment equal to 7.0% of the aggregate proceeds raised from the sale of Units to subscribers introduced to the Corporation by Haywood and 7.0% of the aggregate Units issued to subscribers introduced to the Corporation by Haywood in non-transferable finder's warrants ("Finder Warrants"), being 16,030 Finder's Warrants. Each Finder Warrant is exercisable and will entitle the holder thereof to acquire one Common Share for a period of 12 months from the date of issuance at an exercise price of $0.45.

The Common Shares, Warrants and Finder's Warrant issued in connection with the Offering and the Common Shares underlying the Warrants and Finder's Warrants will be subject to a statutory hold period of four months plus one day from the date of completion of the Offering, being February 17, 2026, in accordance with applicable securities legislation.

Insiders of the Corporation (as such term is defined under the policies of the TSX Venture Exchange (the "TSXV")) purchased a total of 142,857 Units in the Offering, which is considered a "related party transaction" within the meaning of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Corporation relied on the exemptions from the formal valuation and minority approval requirements of MI 61-101 based on a determination that the fair market value of the Offering, insofar as it involves the Insiders, does not exceed 25% of the market capitalization of the Corporation. No new Insiders and no Control Persons were created in connection with the Offering (as such terms are defined under the policies of the TSXV).

For more information concerning the Corporation, please refer to the Corporation's profile on the SEDAR+ website at www.sedarplus.ca.

Forward-Looking Information

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "intend", "may", "will", "expect", and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Corporation's current beliefs or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this press release contains forward-looking information with respect to the principal uses of the proceeds of the Offering. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the Corporation. The material facts and assumptions include the intended use of proceeds remaining in the best interests of the Corporation. The Corporation cautions the reader that the above list of risk factors is not exhaustive. The forward-looking information contained in this release is made as of the date hereof and the Corporation is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Due to the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward- looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of the content of this release.

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities Laws.

THE SECURITIES OFFERED HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS. THIS PRESS RELEASE SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THE SECURITIES IN ANY STATE IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/270807

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Discusses Essential3 Topline Results and Next Steps in Essential Tremor Program October 16, 2025 8:00 AM EDT

Company Participants

Marcio Souza - President, CEO & Director

Conference Call Participants

Daniel Ferry - Lifesci Advisors, LLC
Ritu Baral - TD Cowen, Research Division
Yasmeen Rahimi - Piper Sandler & Co., Research Division
Joon Lee - Truist Securities, Inc., Research Division
Yatin Suneja - Guggenheim Securities, LLC, Research Division
Jay Olson - Oppenheimer & Co. Inc., Research Division
Brian Skorney - Robert W. Baird & Co. Incorporated, Research Division
Douglas Tsao - H.C. Wainwright & Co, LLC, Research Division
Francois Brisebois
Justin Walsh - JonesTrading Institutional Services, LLC, Research Division
Ami Fadia - Needham & Company, LLC, Research Division

Presentation

Operator

Good day. Thank you for standing by. Welcome to the Praxis Precision Medicines Essential3 Topline Results Conference Call. [Operator Instructions] Please note that today's conference may be recorded.

I will now hand the conference over to your speaker host, Dan Ferry. Please go ahead.

Daniel Ferry
Lifesci Advisors, LLC

Good morning, and welcome to the Praxis Precision Medicines Essential3 Topline Results Conference Call. This call is being webcast live and can be accessed on the Investors section of Praxis' website at www.praxismedicines.com.

Please note that remarks made during this call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These may include statements about the company's future expectations and plans, clinical development time lines and financial projections. While these forward-looking statements represent Praxis' views as of today, they should not be relied upon as representing the company's views in the future. Praxis may update these statements in the future, but is not taking on an obligation to do so. Please refer to Praxis' most recent filings with the Securities and Exchange Commission for a discussion of certain risks and uncertainties associated with the company's business.

Recommended For You

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

By

PYMNTS
 | 
October 16, 2025

 | 

JPMorgan Chase is reportedly “looking at” banks in Europe and Latin America.

Reuters reported that JPMorgan Chase CEO Jamie Dimon said this Thursday (Oct. 16), without specifying if he meant the bank was considering acquisitions. A JPMorgan spokesperson declined Reuters’ request to elaborate on the remarks.

According to the Reuters report, Dimon said at an event: “We are looking at all the banks over there [in Europe]. … We are looking at Latin American banks too.”

JPMorgan launched its Chase digital retail bank in the United Kingdom in 2021 and said earlier this year that it will expand that bank to Germany in the second quarter of 2026, per the report.

It was reported in September that the Chase digital retail bank’s first product in Germany will be a savings account and that its operations in the country would be “gradually expanded.”

Dimon told a German newspaper in 2023: “It has always been clear to us that we want to introduce Chase not only in the U.K., but also in Germany and other European countries. We have ambitious plans.”

Advertisement: Scroll to Continue

When the Chase digital bank launched in the U.K., it closed out its first year with £10 billion in deposits and 1 million customers.

“We set out to offer customers good value banking products with a straightforward experience delivered through an easy-to-use app, and we’re excited that consumers have responded so positively to our offer in our first year,” a Chase executive said in a September 2022 press release.

On Oct. 1, U.K. wealth management platform Nutmeg, which was acquired by JPMorgan Chase in 2021, said it will be rebranded as J.P. Morgan Personal Investing on Nov. 3.

The platform will also be expanded to include new products and services designed to help people reach their financial goals, including a wealth planner feature, a do-it-yourself investment platform and, for select clients, access to a dedicated relationship manager who can provide financial guidance.

“J.P. Morgan Personal Investing will continue to provide all the existing Nutmeg products and services, and we will add some new benefits too,” Nutmeg said in an Oct. 1 blog post.

By Reuters

October 16, 202511:38 PM UTCUpdated ago

Workers clean the windows of a building of Roche in Rotkreuz May 27, 2020. REUTERS/Arnd Wiegmann Purchase Licensing Rights, opens new tab

Oct 17 (Reuters) - Chinese biotech Hansoh Pharma

(3692.HK), opens new tab said on Friday its units have signed a license agreement worth up to $1.45 billion with Roche's

(ROG.S), opens new tab subsidiary for an investigational treatment of colorectal cancer and other solid tumors.

Sign up here.

Reporting by Sneha Kumar in Bengaluru; Editing by Shailesh Kuber

Our Standards: The Thomson Reuters Trust Principles., opens new tab

October 16, 2025 7:36 PM EDT | Source: Sage Potash Corp.
Vancouver, British Columbia--(Newsfile Corp. - October 16, 2025) - Sage Potash Corp. (TSXV: SAGE) (OTCQB: SGPTF) ("Sage Potash" or the "Company") is pleased to announce the results of the annual general and special meeting of the shareholders of the Company held on October 16, 2025 (the "Meeting").

A total of 12,559,870 common shares of the Company were represented at the Meeting in person or by proxy, representing approximately 11.89% of the total votes attached to all issued and outstanding common shares of the Company as of the record date on September 11, 2025.

All matters put forth at the Meeting were approved as follows:

MOTIONSNUMBER OF SHARESPERCENTAGE OF VOTES CASTFORAGAINSTWITHELD / 
ABSTAINFORAGAINSTWITHELD / 
ABSTAINSetting Number of Directors12,555,4824 ,388N/A99.97%0.03%N/AElection of Directors:
(i) Peter Hogendoorn8,135,130N/A444,50094.82%N/A5.18%(ii) Gordon Ellis7,793,600N/A786,03090.84%N/A9.16%(iii) Matthew Lechtzier7,835,600N/A744,03091.33%N/A8.67%(iv) David Reid7,835,600N/A744,03091.33%N/A8.67%(v) Stockwell Day8,322,630N/A257,00097.00%N/A3.00%Appointment of Auditor12,555,482N/A4,38899.97%N/A0.03%Approval of Stock Option Plan Amendments8,399,795179,835N/A97.90%2.10%N/ARatification of Stock Option Grants (by disinterested shareholders)7,507,740191,835N/A97.51%2.49%N/ASage Potash further confirms that, following its May 16, 2025 news release announcing certain shares for debt transactions (the "Shares for Debt News Release") and subject to final acceptance of the TSX Venture Exchange ("TSXV"), the Company is only proceeding at this time with issuing 500,000 common shares at the deemed price of $0.27 per share as disclosed in the Shares for Debt News Release following a shares for debt agreement date of May 16, 2025, resulting in the settlement of a total of $135,000. This shares for debt transaction is with one creditor that is not a 'Non-Arm's Length Party' to the Company within the meaning of TSXV policies. The 500,000 common shares being issued under this shares for debt transaction will be subject to a four month hold period from the date of issuance.

About Sage Potash Corp.

Sage Potash Corp. (TSXV: SAGE) (OTCQB: SGPTF) is dedicated to the development of its flagship Sage Plain Potash Project, located in the Paradox Basin, Utah. With a large and high-grade resource base, the Company is advancing toward its goal of establishing a secure and sustainable domestic potash production platform in the United States. Sage Potash is committed to food security, environmental stewardship, and creating value for shareholders and stakeholders alike.

For more information, please visit: www.sagepotash.com.

On behalf of the Board of Directors

Peter Hogendoorn - Chief Executive Officer; (604) 764-2158
Rod Reum - Chief Financial Officer

For further information, please contact:
Marcus van der Made
E: [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward-Looking Statements

This news release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable securities legislation. The forward-looking statements herein are made as of the date of this news release only, and the Company does not assume any obligation to update or revise them to reflect new information, estimates or opinions, future events or results or otherwise, except as required by applicable law. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budgets", "scheduled", "estimates", "forecasts", "predicts", "projects", "intends", "targets", "aims", "anticipates" or "believes" or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. Forward-looking information in this news release includes, but is not limited to, statements with respect to future events or future performance of Sage Potash and with respect to the shares for debt transaction, including regarding the proposed issuance of securities. Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of the Company to control or predict, that may cause the Company's actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out herein, including, but not limited to, the risk factors set out under the heading "Risk Factors and Uncertainties" in the Company's Management's Discussion & Analysis available for review under the Company's profile at www.sedarplus.ca. Such forward-looking information represents management's best judgement based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/270801

Planet Labs PBC (NYSE:PL) Analyst/Investor Day October 16, 2025 9:00 AM EDT

Company Participants

Cleo Palmer-Poroner
William Marshall - Co-Founder, CEO & Chairman of the Board
Charlie Candy - Chief Revenue Officer
Robert Schingler - Co-Founder, Chief Strategy Officer & Inside Director
Ashley Whitfield Johnson - President & CFO

Conference Call Participants

Oleksii Reznikov
Colin Canfield - Cantor Fitzgerald & Co., Research Division
Christopher Quilty - Quilty Space Inc., Research Division
Mike Latimore - Northland Capital Markets, Research Division
Sam Brandeis - Wedbush Securities Inc., Research Division
Mariana Perez Mora - BofA Securities, Research Division
Greg Pendy

Presentation

Cleo Palmer-Poroner

Hi, folks. Good morning. Am I coming through all right? Okay. Hello. We're so glad you could join us. Welcome to Planet's 2025 Investor Day. We're glad you're here.

Now before we jump in, I'd like to remind everyone that today's presentation contains forward-looking statements and statements about our long-term targets and goals. Forward-looking statements are subject to the risks and uncertainties, as detailed in our SEC filings. We encourage everyone to review our filings, which are available on our Investor Relations website and the SEC's website. Additionally, the slides from today are available on Planet's Investor Relations website. We encourage everyone to review the disclaimers included in the accompanying slide presentation as well as our filings.

I'd now like to introduce today's speakers. We have Will Marshall, CEO and Co-Founder; Charlie Candy, Chief Revenue Officer; Robbie Schingler, Chief Strategy Officer and Co-Founder; and Ashley Johnson, President and CFO.

Here's our agenda for the day. First, Will will give you the Planet overview and the view from above. Next, Charlie will talk about the business momentum, driven by AI-enabled solutions and satellite services. We also have a very special guest today, Oleksii Reznikov, the former Minister of Defense for Ukraine. Robbie will discuss Planet's world-class execution and space featuring a testimonial from our partner, JSAT. Will will return to

Recommended For You

NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of KBR, Inc. (NYSE: KBR) between May 6, 2025 and June 19, 2025, both dates inclusive (the “Class Period”), of the important November 18, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.

SO WHAT: If you purchased KBR securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the KBR class action, go to https://rosenlegal.com/submit-form/?case_id=42136 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 18, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) despite the knowledge that the U.S. Department of Defense’s Transportation Command (TRANSCOM) had, for months, had material concerns with HomeSafe’s ability to fulfill the Global Household Goods Contract, defendants claimed that the partnership was without issue, and would ramp up in future quarters; and (2) as a result, defendants’ statements about KBR’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the KBR class action, go to https://rosenlegal.com/submit-form/?case_id=42136 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

Prologis Co-Founder, Chairman, and CEO Hamid Moghadam joins 'Mad Money' host Jim Cramer to talk its real estate portfolio, supply and demand in the data center arena, and much more.

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public. So What: If you purchased agilon health securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arr.

REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted a non-transferrable voucher for daraxonrasib (RMC-6236), the company’s RAS(ON) multi-selective inhibitor, under the Commissioner's National Priority Voucher (CNPV) pilot program.

Daraxonrasib is being studied in two global Phase 3 clinical trials, RASolute 302 in patients with previously treated metastatic pancreatic ductal adenocarcinoma and RASolve 301 in patients with previously treated metastatic non-small cell lung cancer.

“We are honored to receive one of the first vouchers awarded under the Commissioner's National Priority Voucher pilot program. As with the Breakthrough Therapy Designation daraxonrasib received earlier this year, we believe this voucher recognizes the large unmet need for new treatments for patients with RAS-addicted cancers and the potential of the investigational drug daraxonrasib to transform treatment for these diseases, including pancreatic cancer,” said Mark A. Goldsmith M.D., Ph.D., chief executive officer and chairman of Revolution Medicines. “With an expected data readout from RASolute 302 in 2026, we look forward to participating in the CNPV program and working with the FDA to bring daraxonrasib to patients.”

The FDA has designed the CNPV pilot program with the goal of accelerating the development and review of certain drugs and biological products that are aligned with U.S. national health priorities and enhancing the health interests of Americans. 

The company is evaluating the impact of the voucher it received under the CNPV pilot program and is not adjusting any of its previously disclosed timelines at this time.

About Daraxonrasib
Daraxonrasib (RMC-6236) is an oral, direct RAS(ON) multi-selective inhibitor with the potential to help address a wide range of cancers driven by oncogenic RAS mutations. Daraxonrasib suppresses RAS signaling by blocking the interaction of RAS(ON) with its downstream effectors. It does so by targeting oncogenic RAS mutations G12X, G13X and Q61X that are common drivers of major cancers, including pancreatic ductal adenocarcinoma (PDAC), non-small cell lung cancer (NSCLC) and colorectal cancer (CRC).

About Revolution Medicines, Inc.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; and zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor, are currently in clinical development. The company anticipates that RMC-5127, a RAS(ON) G12V-selective inhibitor, will be its next RAS(ON) inhibitor to enter clinical development. Additional development opportunities in the company’s pipeline focus on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C). For more information, please visit www.revmed.com and follow us on LinkedIn.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this press release that are not historical facts may be considered "forward-looking statements," including without limitation statements regarding: the company’s development opportunities, plans and timelines and its ability to build or advance its portfolio and R&D pipeline; the company’s expectations regarding timing of clinical trial initiation, enrollment and data readouts or disclosures; the potential for any of the company’s investigational products, including daraxonrasib, to become a standard of care; and the operations of CNPV pilot program and the impact of the company’s participation in this program. Forward-looking statements are typically, but not always, identified by the use of words such as "will," "believe," "plan," "anticipate," "estimate," "expect," and other similar terminology indicating future results. Such forward-looking statements are subject to substantial risks and uncertainties that could cause the company’s development programs, future results, performance or achievements to differ materially from those anticipated in the forward-looking statements. Such risks and uncertainties include without limitation risks and uncertainties inherent in the drug development process, including the company’s programs’ current stage of development, the process of designing and conducting preclinical and clinical trials, risks that the results of prior clinical trials may not be predictive of future clinical trials, clinical efficacy, or other future results, the regulatory approval processes, the timing of regulatory filings, the challenges associated with manufacturing drug products, the company’s ability to successfully establish, protect and defend its intellectual property, other matters that could affect the sufficiency of the company’s capital resources to fund operations, reliance on third parties for manufacturing and development efforts, changes in the competitive landscape, and the effects on the company’s business of the global events, such as international conflicts or global pandemics. For a further description of the risks and uncertainties that could cause actual results to differ from those anticipated in these forward-looking statements, as well as risks relating to the business of Revolution Medicines in general, see Revolution Medicines’ Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on August 6, 2025, and its future periodic reports to be filed with the SEC. Except as required by law, Revolution Medicines undertakes no obligation to update any forward-looking statements to reflect new information, events or circumstances, or to reflect the occurrence of unanticipated events.

Revolution Medicines Media & Investor Contact:
[email protected]
[email protected]

TSX:ORV

, /PRNewswire/ - Orvana Minerals Corp. (TSX: ORV) (the "Company" or "Orvana") is pleased to report production and exploration updates for the fourth quarter of fiscal year 2025 ("Q4 FY2025) ending September 30, 2025 from Orovalle (Spain).

Highlights

Figure 1. Longitudinal section B-B’ and intercepts (not true width) (CNW Group/Orvana Minerals Corp.)

Figure 2. Plan view (CNW Group/Orvana Minerals Corp.)

Q4 FY2025 Production: 7,587 gold equivalent ounces (6,317 gold ounces, 0.8 million copper pounds and 24,279 silver ounces).
FY2025 Production: 35,705 gold equivalent ounces (29,276 gold ounces, 3.6 million copper pounds and 115,466 silver ounces).
Q4 FY2025 Exploration: 2,652 m of Infill and Brownfield drilling, with key intercepts in Area A2 as follows:

18.75 g/t gold over 8.7 m
14.68 g/t gold over 9.0 m
11.02 g/t gold over 16.8 m
9.36 g/t gold over 26.7 m

Following the strong exploration progress and steady operations at Orovalle, management provided an update on the Company's strategic priorities at Orovalle. Juan Gavidia, CEO of Orvana, commented,  "Encouraging drilling results at El Valle Boinás during the quarter support the ongoing brownfield program, which aims to increase resource inventory and replace mined reserves. Our objective remains to manage mineral resources efficiently to support mine life extension, subject to ongoing geological and operational assessments".

"This quarter marked a key milestone: the ramp-up of operations at Carlés. In 2026, with both El Valle Boinás and Carlés operating in parallel, we aim to reduce operational risk associated with ore extraction by having access to ore from two independent deposits ", he added.

Orovalle – Q4 FY2025 Production Results

The mill processed approximately 101,140 dry tonnes during Q4 FY2025, 13% lower than the prior quarter as a result of planned summer maintenance shutdowns. At fiscal year-end, 12,096 wet tonnes were in stockpiles, which will be processed during the first quarter of fiscal 2026.
6,317 gold ounces produced in Q4 FY2025, 26% lower than the previous quarter primarily due to 13% lower tonnes milled and 12% lower gold grade,  mainly resulting from processing ore sourced from different areas of the El Valle Boinás mine.
0.8 million copper pounds produced in Q4 FY2025, 13% lower than the previous quarter mainly due to lower tonnes processed.
Orovalle –FY2025 Production Results

Gold production of 29,276 ounces during the fiscal year 2025 was approximately 2% below the lower end of the fiscal year 2025 production guidance of 30,000 to 31,000 ounces. The variance primarily reflects the concentration of stope ore extraction in the latter half of September, which limited in-month processing capacity. The material was therefore stockpiled and is scheduled for milling in fiscal 2026.
Copper production of 3.6 million pounds during the fiscal year 2025 met the 2025 production guidance of 3,500 to 3,700 K lbs.

Q4 FY2025 

Q3 FY2025 

Q4 FY2024 

FY2025 

FY 2025 

Revised Guidance 

Ore milled (tonnes)

101,140

116,626

139,275

447,687

Gold equivalent (oz)(1)     

7,587

10,008

11,862

35,705

Gold

    Grade (g/t)

2.13

2.43

2.39

2.20

    Recovery (%)

91.0

93.6

92.5

92.4

    Production (oz)

6,317

8,536

9,888

29,276

30,000 - 31,000

Copper

     Grade (%)

0.44

0.42

0.41

0.44

     Recovery (%)

79.3

82.0

75.8

82.9

     Production (K lbs)

773

886

961

3,612

3,500 - 3,700

Silver

     Grade (g/t)

9.54

9.86

8.9

10.0

     Recovery (%)

78.2

80.4

75.0

80.0

     Production (oz)

24,279

29,752

29,864

115,466

(1) Gold Equivalent Ounces ("GEO") is a Non-GAAP Financial Performance Measure. Non-GAAP measures do not have standardized meanings under IFRS and may not be comparable to similar measures of other issuers. For further information and detailed reconciliations, please see the "Non-GAAP Financial Performance Measures" section of the Company's latest MD&A. GEO were calculated using the following average market prices:

Q4 FY2025:  $3,455.50/oz Au, $39.38/oz Ag, $4.44/lb Cu
Q3 FY2025:  $3,279.16/oz Au, $33.64/oz Ag, $4.32/lb Cu
Q4 FY2024:  $2,476.80/oz Au, $29.42/oz Ag, $4.17/lb Cu
FY2025:        $3,064.71/oz Au, $34.07/oz Ag, $4.29/lb Cu

Orovalle – Q4 FY2025 Drilling Update

The El Valle Boinás program remains focused on oxide areas, with the goal to extend the A2 mineralization southward. Drilling returned multiple high-grade intercepts between 160 m.a.s.l. and 360 m.a.s.l. outside of the previously defined resource boundary, supporting the target of expanding resources. See Figure 1 below for drilling results carried out in Q4 along a longitudinal section.

A total of 1,920 m were drilled in A2 across 8 drill holes, successfully extending the mineralized structure over a 40 m strike length and maintaining a vertical depth of 120 m.

Mineralization is concentrated within bands, with variable thickness, between 5-10 m, of altered skarn and semi-jasperoid breccias, preferentially along fractures N30ºE/35SE within the limestone; subsequently, the intrusion of porphyry dikes led to silicification and mineral enrichment of these bands. The mineralized bands are dipping towards the southeast, with potential for further extension in that direction.

Figure 2 presents a plan view of the two most recently drilled sections: A–A', whose results were disclosed in the January 16, 2025 press release, and B–B' (see Figure 1). The figure illustrates that the oxide structures remain open to the south.

The drilling program for the first quarter of fiscal 2026 ("Q1 FY2026") is focused on further defining and expanding the mineral potential of these structures to the south.

At the Ortosa-Godan Project, a total of 493 metres were drilled during the quarter, completing the third drill hole of the FY2025 campaign. Drill core sample analyses are currently underway and are expected to be completed during Q1 FY2026. Based on the results obtained, the next steps will be defined.

Summary of Q4 Drilling Program:

Drilled Meters

Infill 

Brownfield 

Greenfield 

TOTAL 

El Valle Boinás

  Area 208 (A2)

-

1,920

-

1,920

  Boinás East (BE)

439

-

-

439

  Boinás South (SB)     

293

-

-

293

Ortosa-Godán

-

-

493

493

TOTAL

732

1,920

493

3,145

Quality Control

Greenfield drill hole samples were sent to an external laboratory (ALS Laboratory) for analyses. Infill and brownfield drill holes samples were analyzed in Orovalle's Laboratory.

Sample preparation was carried out at the El Valle facility. All diamond core samples have been prepared using the following procedure, once split:

The core samples are dried at a temperature of 105ºC and then crushed through a jaw crusher to 70%<6 mm. The coarse-crushed sample is further reduced to 70%<425 microns using an LM5 bowl-and-puck pulverizer. An Essa rotary splitter is used to take a 450 g to 550 g sub-sample of each split for pulverizing. The remaining reject portion is bagged and stored. The sample is reduced by 85% to a nominal -200 mesh using an LM2 bowl-and-puck pulverizer. 150 g sub-samples are split using a special vertical-sided scoop to cut channels through the sample which has been spread into a pancake on a sampling mat.  Samples are then sent to the laboratory for gold and base metal analysis. Leftover pulp is bagged and stored. After sample preparation, 30g samples are analyzed for Au by fire assay with an atomic absorption.

The technical information in this news release, including geological, assay, and drilling interpretation data, has been reviewed and approved by Guadalupe Collar Menéndez, a Qualified Person under National Instrument 43-101 and an employee of Orovalle Minerals S.L., a subsidiary of Orvana.

Consolidated Operational and Financial Performance:

Project updates for Bolivia and Argentina, and Q4 FY2025 consolidated operational and financial highlights will be released with the fourth quarter financials, expected mid-December, 2025.

FY2026 guidance will be released with FY2025 year-end financials.

ABOUT ORVANA – Orvana is a multi-mine gold-copper-silver company. Orvana's assets consist of the producing Orovalle operation in northern Spain; the Don Mario operation in Bolivia, currently in plant expansion; and the Taguas property located in Argentina. Additional information is available at Orvana's website (www.orvana.com).

Cautionary Statements – Forward-Looking Information

Certain statements in this news release constitute forward-looking statements or forward-looking information within the meaning of applicable securities laws ("forward-looking statements"). Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, potentials, future events or performance (often, but not always, using words or phrases such as "believes", "expects", "plans", "estimates" or "intends" or stating that certain actions, events or results "may", "could", "would", "might", "will", "are projected to" or "confident of" be taken or achieved) are not statements of historical fact, but are forward-looking statements.

The forward-looking statements herein relate to, among other things, including Orvana's expectations for the ramp-up of operations at the Carlés Mine and its impact on reducing operational risk and improving production consistency, as well as the planned parallel operation of El Valle Boinás and Carlés Mines; the ability to extend mine life and replace mined reserves through brownfield exploration at El Valle Boinás, and the potential to expand mineral resources and define mineralized structures at Orovalle and Ortosa-Godán; Orvana's ability to achieve improvement in free cash flow; the ability to maintain expected mining rates and expected throughput rates at El Valle Plant; the potential to extend the mine life of El Valle and Don Mario beyond their current life-of-mine estimates including specifically, but not limited to, Orvana's ability to optimize its assets to deliver shareholder value; estimates of future production (including without limitation, production guidance), operating costs and capital expenditures; mineral resource and reserve estimates; statements and information regarding future feasibility studies and their results; future transactions; future metal prices; the ability to achieve additional growth and geographic diversification; and future financial performance, including the ability to increase cash flow and profits; future financing requirements; mine development plans; the possibility of the conversion of inferred mineral resources to mineral reserves.

Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company as of the date of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies, which includes, without limitation, as particularly set out in the notes accompanying the Company's most recently filed financial statements. The estimates and assumptions of the Company contained or incorporated by reference in this news release, which may prove to be incorrect, include, but are not limited to the various assumptions set forth herein and in Orvana's most recently filed Management's Discussion & Analysis and Annual Information Form in respect of the Company's most recently completed fiscal year (the "Company Disclosures") or as otherwise expressly incorporated herein by reference as well as: timely completion of planned maintenance and ramp-up activities at the Orovalle mill and Carlés operation, there being no significant disruptions affecting operations, whether due to labour disruptions, supply disruptions, power disruptions, damage to equipment or otherwise; permitting, development, operations, expansion and acquisitions at El Valle, Don Mario and Taguas being consistent with the Company's current expectations; political developments in any jurisdiction in which the Company operates being consistent with its current expectations; certain price assumptions for gold, copper and silver, which are subject to fluctuation and volatility beyond the Company's control;; prices for key supplies being approximately consistent with current levels; stable labour, energy supply, and logistics conditions in the jurisdictions where the Company operates; production and cost of sales forecasts meeting expectations; the accuracy of the Company's current mineral reserve and mineral resource estimates; labour and materials costs increasing on a basis consistent with Orvana's current expectations; and the availability of necessary funds to execute the Company's plan. Without limiting the generality of the foregoing, this news release also contains certain "forward-looking statements" within the meaning of applicable securities legislation, including, without limitation, references to the results of the Company's exploration activities, including but not limited to, drilling results and analyses, mineral resource estimation, conceptual mine plan and operations, internal rate of return, sensitivities, taxes, net present value, potential recoveries, design parameters, operating costs, capital costs, production data and economic potential; the timing and costs for production decisions; permitting timelines and requirements; exploration and planned exploration programs; and the Company's general objectives and strategies.

A variety of inherent risks, uncertainties and factors, many of which are beyond the Company's control, affect the operations, performance and results of the Company and its business, and could cause actual events or results to differ materially from estimated or anticipated events or results expressed or implied by forward looking statements. Some of these risks, uncertainties and factors include: delays or difficulties in obtaining or maintaining necessary permits, including tailings storage and environmental authorizations at Orovalle; the potential impact of global health and global economic conditions on the Company's business and operations, including: our ability to continue operations; and our ability to manage challenges presented by such conditions; the general economic, political and social impacts of  the continuing conflict between Russia and Ukraine, our ability to support the sustainability of our business including through the development of crisis management plans, increasing stock levels for key supplies, monitoring of guidance from the medical community, and engagement with local communities and authorities; fluctuations in the price of gold, silver and copper; the need to recalculate estimates of resources based on actual production experience; the failure to achieve production estimates; variations in the grade of ore mined; variations in the cost of operations, including increases in energy, power, and environmental compliance costs; the availability of qualified personnel; the Company's ability to obtain and maintain all necessary regulatory approvals and licenses; delays or difficulties in obtaining or maintaining necessary permits, including Orovalle's ability to complete the permitting process of the El Valle Tailings Storage Facility increasing the storage capacity, and obtaining environmental authorizations at Orovalle; Orovalle's ability to complete the stabilization project of the legacy open pit wall; the Company's ability to use cyanide in its mining operations; risks generally associated with mineral exploration and development, including the Company's ability to continue to operate the El Valle and/or ability to resume operations at the Carlés Mine; the Company's ability to successfully implement an acid leaching circuit and ancillary facilities to process the current oxides stockpiles at Don Mario; the Company's ability to successfully carry out development plans at Taguas; sufficient funding to carry out exploration and development plans at Taguas and to process the oxides stockpiles at Don Mario; EMIPA's ability to complete the placement of EMIPA Bonds II Issuance; EMIPA's ability to complete the required funding for the OSP; the Company's ability to acquire and develop mineral properties and to successfully integrate such acquisitions; the Company's ability to execute on its strategy; the Company's ability to obtain financing when required on terms that are acceptable to the Company; challenges to the Company's interests in its property and mineral rights; current, pending and proposed legislative or regulatory developments or changes in political, social or economic conditions in the countries in which the Company operates; general economic conditions worldwide; the challenges presented by global health conditions; fluctuating operational costs such as, but not limited to, power supply costs; current and future environmental matters; and the risks identified in the Company's disclosures. This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements and reference should also be made to the Company's Disclosures for a description of additional risk factors. Additional risk factors are described in the Company's most recent Management's Discussion and Analysis and Annual Information Form, available under the Company's profile at www.sedarplus.ca.

Any forward-looking statements made herein with respect to the anticipated development and exploration of the Company's mineral projects, and the timing and results of processing stockpiled material scheduled for FY2026, including variations in ore grade, recoveries, or throughput that could affect realized production,  are intended to provide an overview of management's expectations with respect to certain future activities of the Company and may not be appropriate for other purposes. Forward-looking statements are based on management's current plans, estimates, projections, beliefs and opinions and, except as required by law, the Company does not undertake any obligation to update forward-looking statements should assumptions related to these plans, estimates, projections, beliefs and opinions change. Readers are cautioned not to put undue reliance on forward-looking statements. The forward-looking statements made in this information are intended to provide an overview of management's expectations with respect to certain future operating activities of the Company and may not be appropriate for other purposes.

SOURCE Orvana Minerals Corp.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

NEW YORK--(BUSINESS WIRE)--Labaton Keller Sucharow LLP (“Labaton”) has filed a securities class action lawsuit (the “Action”) on behalf of its client the Electrical Workers Pension Fund, Local 103, I.B.E.W. (“Local 103”) against Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) and certain of its executives (collectively, “Defendants”). The Action, which is captioned Electrical Workers Pension Fund, Local 103, I.B.E.W. v. Baxter International, Inc., No. 25-cv-12672 (N.D. Ill.),.

Image Credits:Lilium

5:19 PM PDT · October 16, 2025

Electric aircraft startup Lilium may have ceased operations a year ago, but its insolvency filing wasn’t quite the end of the German-based company.

There were multiple failed attempts to restructure the company, including a last-ditch effort by Mobile Uplift Corporation, a company set up by investors from Europe and North America, to acquire the operating assets of the startup’s two subsidiaries. Ultimately, a bankruptcy administrator put the company’s assets through a competitive bid process.

Now, some of its tech will live on over at Archer Aviation, which beat out Ambitious Air Mobility Group and U.S. based Joby Aviation with the winning bid of €18 million ($21 million) for all 300 of Lilium’s patent assets. Joby Aviation confirmed it participated in the bid.

Lilium, which was founded in 2015, was developing a vertical take-off and landing aircraft with speeds of up to 100 km/h. The company raised more than $1 billion from investors before going public in 2021 on the Nasdaq Exchange via a reverse merger with a blank-check company, SPAC Qell. While it managed to land high-profile investors like Tencent and lock in customers, including an order for 100 electric jets from Saudi Arabia, it burned through cash long before it could deliver a product.

An Archer spokesperson said the patents span critical eVTOL (electric vertical takeoff and landing) technologies, including high-voltage systems, flight controls, ducted fans, and advanced aircraft design. The new patents represent a “strong addition” to Archer’s growing IP portfolio, which now totals more than 1,000 global patent assets, the spokesperson noted in an email.

What Archer plans to do with those patents isn’t totally clear, although there are hints. Lilium’s electric ducted fans would be a good application for light-sport or regional electric flight — which goes beyond Archer’s original mission.

Archer, which went public in 2021 via a merger with a special purpose acquisition company, initially focused on developing an air taxi network. It added a defense program in December, which included an exclusive deal with weapons manufacturer Anduril to jointly develop a hybrid gas-and-electric-powered VTOL aircraft for critical defense applications. 

Techcrunch event

San Francisco
|
October 27-29, 2025

Topics

Kirsten Korosec is a reporter and editor who has covered the future of transportation from EVs and autonomous vehicles to urban air mobility and in-car tech for more than a decade. She is currently the transportation editor at TechCrunch and co-host of TechCrunch’s Equity podcast. She is also co-founder and co-host of the podcast, “The Autonocast.” She previously wrote for Fortune, The Verge, Bloomberg, MIT Technology Review and CBS Interactive.

You can contact or verify outreach from Kirsten by emailing [email protected] or via encrypted message at kkorosec.07 on Signal.

View Bio

You've got two more months until the two apps are gone.

Aaron Pruner Writer

Aaron covers what's exciting and new in the world of home entertainment and streaming TV. Previously, he wrote about entertainment for places like Rotten Tomatoes, Inverse, TheWrap and The Hollywood Reporter. Aaron is also an actor and stay-at-home dad, which means coffee is his friend.

Meta is discontinuing its desktop Messenger apps for Windows and Mac. As of Dec. 15, you'll need to head to Facebook to continue chatting through the app on your computer. 

Don't miss any of our unbiased tech content and lab-based reviews. Add CNET as a preferred Google source.

Once the sundowning process begins, users will receive an in-app notification. They will have a 60-day window to continue using Messenger before the app is permanently shut down. If you want to save chat history, Meta suggests activating secure storage before the app is gone forever. Otherwise, your chat history will be gone forever, as well.

The Messenger desktop app is no longer available on the Apple App Store. After Dec. 15, Meta users who try to access Messenger on desktop will be redirected to Facebook.com. Users without a Facebook account will be redirected to Messenger.com.

Laptops

Desktops & Monitors

Computer Accessories

Photography

Tablets & E-Readers

3D Printers

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Silver has reached a historic 45-year high, while Bitcoin and Ethereum experience notable declines. This reversal between traditional and digital assets highlights a potential rotation of capital toward tangible investments, sparking debates over whether Bitcoin's “digital gold” era is under threat.

Crypto traders have sounded the alarm on an expected Bitcoin (BTC) price correction as sideways trading enters the third day. Bitcoin price, which declined to $108k from an all-time high above $125k, has faced short-term resistance following investors’ gradual pullback. The wider market also reacted similarly, with the 24-hour trading pattern of most altcoins showing flash dips.

Will Bitcoin Price Remain Defiant?
Expert trader Ali Martinez signaled the possibility of a BTC price crash to $96k if bulls miss the next short-term rally. In an X post, Martinez told the community that the asset must reclaim the $119k mark to keep the bullish momentum alive. Alternatively, pricing bands will signal a drop to $96k.

In practice, Bitcoin needs increased buyer strength from whales and retail markets to prevent a reversal. Traders are closely monitoring BTC support levels and the ability to hold key resistance in the short term. A slight break could mean sentiments shift from bullish to highly cautious, signaling a price drop. This is harmful to the gains recorded in the last three quarters as institutional inflows hit all-time highs. 

This year, the Bitcoin price has steadily increased with periodic metrics pointing upward. After the positive trend in the mainstream United States, institutional capital flowed to the asset and trickled to other altcoins. As a result, Bitcoin hit multiple all-time highs after attracting huge corporate treasuries. While bear sentiments persist, some traders point to these treasuries as key behind the asset’s stability.  

Per Bitwise data, corporate Bitcoin treasuries hold $117 billion in assets, marking a 40% increase in three months. The last quarter saw the number of firms holding assets surge to 172, with Michael Saylor’s Strategy still at the top. Among these firms, publicly listed firms picked up the most BTC, a 20.68% increase. Aside from Strategy, firms like Metaplanet and Galaxy also boosted purchases and rolled out new financing plans. 

Advertisement
 

Bullish traders also cite the crypto derivatives markets as reasons to remain cautiously optimistic in the coming weeks. Meanwhile, CryptoQuant analysts noted that Bitcoin’s new investor supply increased since the last dip. For context, the number spiked from 1.6 million BTC to 1.87 million BTC within days.

“The rapid increase in STH supply signifies that the necessary market liquidity for future upward price movements is being replenished. The recent price dip was effectively utilized as a crucial buying opportunity by new market participants, establishing a new, robust demand floor that can absorb future minor sell-offs. Low-Profit Cost Basis Reduces Selling Pressure: This accumulation involves the distribution of older coins (likely from profit-taking Long-Term Holders or LTHs) being passed to these newer buyers,” they added.